Specificity of Mimotope-Induced Anti-High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Antibodies Does Not Ensure Biological Activity

作者: Julia Latzka , Sonja Gaier , Gerlinde Hofstetter , Nina Balazs , Ursula Smole

DOI: 10.1371/JOURNAL.PONE.0019383

关键词:

摘要: Vaccines based on peptide mimics (mimotopes) of conformational tumor antigen epitopes have been investigated for a variety human tumors including breast cancer, expressing the carcinoembryonic antigen, B cell lymphoma, neuroblastoma, and melanoma. In our previous work, we designed vaccine mimotope high molecular weight-melanoma associated (HMW-MAA) that elicited HMW-MAA-specific antibodies (Abs) with anti-tumor activity in vitro vivo. this study, aimed to identify mimotopes additional distinct HMW-MAA epitopes, since they could be used construct polymimotope melanoma vaccine. For purpose, random phage libraries were screened anti-HMW-MAA monoclonal (mAbs) VT80.12 VF1-TP43 yielding one ligand each mAb. Both peptides inhibited binding corresponding mAb HMW-MAA. Furthermore, when coupled carrier protein keyhole limpet hemocyanin (KLH), both peptide-specific Abs rabbits or BALB/c mice, but only isolated mice. However, latter had no detectable effect cells vitro. These results describe limitations related display technique emphasize need characterize functional properties utilized isolate epitopes.

参考文章(36)
Michael Campoli, Soldano Ferrone, Xinhui Wang, Functional and clinical relevance of chondroitin sulfate proteoglycan 4. Advances in Cancer Research. ,vol. 109, pp. 73- 121 ,(2010) , 10.1016/B978-0-12-380890-5.00003-X
Stefan Wagner, Christine Hafner, Dorothee Allwardt, Joanna Jasinska, Soldano Ferrone, Christoph C. Zielinski, Otto Scheiner, Ursula Wiedermann, Hubert Pehamberger, Heimo Breiteneder, Vaccination with a Human High Molecular Weight Melanoma-Associated Antigen Mimotope Induces a Humoral Response Inhibiting Melanoma Cell Growth In Vitro Journal of Immunology. ,vol. 174, pp. 976- 982 ,(2005) , 10.4049/JIMMUNOL.174.2.976
Kevin Holmes, Larry M. Lantz, B.J. Fowlkes, Ingrid Schmid, Janis V. Giorgi, Preparation of cells and reagents for flow cytometry. Current protocols in immunology. ,vol. 44, pp. 0- 0 ,(2001) , 10.1002/0471142735.IM0503S44
Federico Perosa, Elvira Favoino, Chiara Vicenti, Andrea Guarnera, Vito Racanelli, Vito De Pinto, Franco Dammacco, Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes. Journal of Immunology. ,vol. 182, pp. 416- 423 ,(2009) , 10.4049/JIMMUNOL.182.1.416
Angelika B. Riemer, Markus Klinger, Stefan Wagner, Astrid Bernhaus, Luca Mazzucchelli, Hubert Pehamberger, Otto Scheiner, Christoph C. Zielinski, Erika Jensen-Jarolim, Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. Journal of Immunology. ,vol. 173, pp. 394- 401 ,(2004) , 10.4049/JIMMUNOL.173.1.394
Morton Dl, Roth Ja, Chee Do, Holmes Ec, Boddie Aw, Production of Melanoma-associated Antigen(s) by a Defined Malignant Melanoma Cell Strain Grown in Chemically Defined Medium Cancer Research. ,vol. 36, pp. 1503- 1509 ,(1976)
Franco Felici, Luisa Castagnoli, Andrea Musacchio, Roberto Jappelli, Gianni Cesareni, Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector Journal of Molecular Biology. ,vol. 222, pp. 301- 310 ,(1991) , 10.1016/0022-2836(91)90213-P
Stefan Wagner, Joanna Jasinska, Heimo Breiteneder, Michael Kundi, Hubert Pehamberger, Otto Scheiner, Christoph C. Zielinski, Ursula Wiedermann, Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice. Breast Cancer Research and Treatment. ,vol. 106, pp. 29- 38 ,(2007) , 10.1007/S10549-006-9469-4